摘要
Osteoarthritis (OA) is the most prevalent degenerative whole-joint disease characterized by cartilage degener-ation, synovial hyperplasia, osteophyte formation, and subchondral bone sclerosis. Currently there are no disease-modifying treatments available for OA because its etiology and pathogenesis are largely unknown. Here we report that a natural carboxylic polyether ionophore that is used as an anti-tumor drug, salinomycin (SAL), may be a promising therapeutic drug for OA in the future. We found that SAL showed no cytotoxicity on mouse chondrocytes and displayed a protective effect against interleukin-1 beta (IL-1 beta), in cultured mouse chondrocytes and cartilage explants. Treatment with low SAL concentrations directly upregulated the anabolism factors collagen II and aggrecan, while it inhibited the catabolic factors matrix metalloproteinase-13 (MMP13) and metalloproteinase with thrombospondin motifs-5 (ADAMTS5) to protect against extracellular matrix (ECM) degradation, and also suppressed inflammatory responses in mouse chondrocytes. Furthermore, SAL reduced the severity of OA-associated changes and delayed cartilage destruction, subchondral bone sclerosis, and osteophyte formation in a destabilized medial meniscus (DMM) surgery-induced mouse OA model. Mechanistically, a low SAL concentration induced anabolism and inhibited catabolism in chondrocytes via inhibiting Lrp6 phosphor-ylation and Wnt/beta-catenin signaling. Our results suggested that SAL may serve as a potential disease-modifying therapeutic against OA pathogenesis.
学科与关键词
- PP2 alleviates the progression of osteoarthritis by inhibiting Wnt/β-catenin and activating TGF-β/Smad signalingZhang, Hao; Zheng, Chuanchuan; Chen, Wei; Li, Xiaoqiang; Wang, Jinshu; Wang, Taikun; Zhao, Qi; Huang, Hao; Li, Yiting; Yang, Chengliang; Xie, Kegong; Pan, Shengcai; Wang, Binghao; Wang, Chong; Tang, Yujin*; Li, Kai*; Liu, Jia*; Wang, LiqiangInternational Immunopharmacology, 2023, 124: 110948.
- Monotropein attenuates apoptosis and pyroptosis in chondrocytes and alleviates osteoarthritis progression in miceLi, Zhen; Chen, Zhenyue; Chen, Jiayi; Liu, Zhutong; Li, Zehui; Sun, He; Wang, Xiaochao; Wei, Jinqiang; Cao, Xuewei*; Zheng, Decai*Chinese Medicine, 2023, 18(1): 42.被引 2
- AMPK activator decelerates osteoarthritis development by inhibition of ?-catenin signaling in chondrocytesZhu, Zhenglin; Huang, Yanran; Li, Jun; Yi, Dan; Liao, Junyi; Xiao, Jun; Xiao, Guozhi; Tong, Liping*; Huang, Wei*; Di, Chen*Journal of Orthopaedic Translation, 2023, 38: 158-166.被引 4
